PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $83,000 | -41.1% | 28,110 | -10.1% | 0.00% | – |
| Q4 2021 | $141,000 | -2.8% | 31,268 | +5.1% | 0.00% | – |
| Q3 2021 | $145,000 | -90.5% | 29,762 | -86.7% | 0.00% | -100.0% |
| Q2 2021 | $1,531,000 | -9.9% | 224,587 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $1,699,000 | +50.9% | 240,597 | +33.7% | 0.00% | 0.0% |
| Q4 2020 | $1,126,000 | -12.9% | 179,964 | -24.7% | 0.00% | 0.0% |
| Q3 2020 | $1,293,000 | +146.8% | 239,011 | +138.2% | 0.00% | – |
| Q2 2020 | $524,000 | +1355.6% | 100,333 | +784.1% | 0.00% | – |
| Q1 2020 | $36,000 | -23.4% | 11,348 | -5.6% | 0.00% | – |
| Q4 2019 | $47,000 | +23.7% | 12,018 | +32.7% | 0.00% | – |
| Q3 2019 | $38,000 | -90.0% | 9,058 | -90.6% | 0.00% | – |
| Q2 2019 | $381,000 | -77.3% | 96,253 | -69.4% | 0.00% | -100.0% |
| Q1 2019 | $1,682,000 | +3.6% | 314,136 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $1,624,000 | -69.8% | 316,661 | -42.9% | 0.00% | -50.0% |
| Q3 2018 | $5,379,000 | -53.9% | 554,609 | -51.5% | 0.00% | -33.3% |
| Q2 2018 | $11,659,000 | +79.7% | 1,143,139 | +129.1% | 0.00% | 0.0% |
| Q1 2018 | $6,487,000 | -3.7% | 499,051 | +32.6% | 0.00% | -25.0% |
| Q4 2017 | $6,734,000 | -32.3% | 376,285 | -5.0% | 0.00% | -42.9% |
| Q3 2017 | $9,943,000 | -2.3% | 396,274 | -6.2% | 0.01% | 0.0% |
| Q2 2017 | $10,175,000 | +120.1% | 422,273 | +75.7% | 0.01% | +133.3% |
| Q1 2017 | $4,623,000 | +136.5% | 240,286 | +89.0% | 0.00% | +50.0% |
| Q4 2016 | $1,955,000 | +13.5% | 127,122 | -4.1% | 0.00% | +100.0% |
| Q3 2016 | $1,723,000 | +30.2% | 132,571 | +39.3% | 0.00% | 0.0% |
| Q2 2016 | $1,323,000 | +208.4% | 95,180 | +235.9% | 0.00% | – |
| Q1 2016 | $429,000 | -21.0% | 28,340 | -1.4% | 0.00% | – |
| Q4 2015 | $543,000 | -42.9% | 28,748 | -42.7% | 0.00% | -100.0% |
| Q3 2015 | $951,000 | -43.5% | 50,171 | -23.3% | 0.00% | 0.0% |
| Q2 2015 | $1,684,000 | +33.1% | 65,414 | +61.6% | 0.00% | 0.0% |
| Q1 2015 | $1,265,000 | -14.1% | 40,484 | +6.0% | 0.00% | 0.0% |
| Q4 2014 | $1,472,000 | – | 38,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |